Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Cerity Partners LLC

Cerity Partners LLC boosted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 43.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,218 shares of the medical instruments supplier’s stock after acquiring an additional 970 shares during the period. Cerity Partners LLC’s holdings in Mettler-Toledo International were worth $4,826,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Gateway Investment Advisers LLC purchased a new stake in Mettler-Toledo International in the 2nd quarter valued at approximately $685,000. Swedbank AB acquired a new stake in shares of Mettler-Toledo International during the first quarter valued at $26,867,000. SG Americas Securities LLC increased its position in Mettler-Toledo International by 52.9% during the 2nd quarter. SG Americas Securities LLC now owns 4,516 shares of the medical instruments supplier’s stock worth $6,312,000 after purchasing an additional 1,562 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock valued at $1,860,000 after purchasing an additional 152 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC raised its stake in Mettler-Toledo International by 212.2% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock valued at $1,828,000 after purchasing an additional 889 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,243.40 on Friday. The business has a 50-day moving average of $1,348.27 and a two-hundred day moving average of $1,395.43. The firm has a market capitalization of $26.24 billion, a PE ratio of 33.52, a P/E/G ratio of 4.04 and a beta of 1.16. Mettler-Toledo International Inc. has a 12 month low of $1,059.08 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.

Insider Activity

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.94% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on MTD. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. lifted their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.